04:11 PM EDT, 03/11/2024 (MT Newswires) -- Pascal Deschatelets, Chief Scientific Officer, on March 08, 2024, sold 69,107 shares in Apellis Pharmaceuticals ( APLS ) for $4,297,549. Following the Form 4 filing with the SEC, Deschatelets has control over a total of 1,115,983 shares of the company, with 1,115,983 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1492422/000112760224009368/xslF345X03/form4.xml